ZA934645B - 17-Alkylketone steroids useful as 5-alpha-reductase inhibitors - Google Patents
17-Alkylketone steroids useful as 5-alpha-reductase inhibitorsInfo
- Publication number
- ZA934645B ZA934645B ZA934645A ZA934645A ZA934645B ZA 934645 B ZA934645 B ZA 934645B ZA 934645 A ZA934645 A ZA 934645A ZA 934645 A ZA934645 A ZA 934645A ZA 934645 B ZA934645 B ZA 934645B
- Authority
- ZA
- South Africa
- Prior art keywords
- alkylketone
- alpha
- reductase inhibitors
- steroids useful
- steroids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
- C07J7/007—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929213835A GB9213835D0 (en) | 1992-06-30 | 1992-06-30 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA934645B true ZA934645B (en) | 1994-01-25 |
Family
ID=10717920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA934645A ZA934645B (en) | 1992-06-30 | 1993-06-26 | 17-Alkylketone steroids useful as 5-alpha-reductase inhibitors |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0651643A4 (pt) |
| JP (1) | JPH08500821A (pt) |
| KR (1) | KR950702118A (pt) |
| CN (1) | CN1095382A (pt) |
| AP (1) | AP412A (pt) |
| AU (1) | AU4545993A (pt) |
| BG (1) | BG99313A (pt) |
| BR (1) | BR9306748A (pt) |
| CA (1) | CA2138956A1 (pt) |
| CZ (1) | CZ334694A3 (pt) |
| FI (1) | FI946189A (pt) |
| GB (1) | GB9213835D0 (pt) |
| HU (1) | HUT69409A (pt) |
| IL (1) | IL106158A0 (pt) |
| MA (1) | MA22927A1 (pt) |
| MX (1) | MX9303970A (pt) |
| NO (1) | NO945074L (pt) |
| OA (1) | OA10122A (pt) |
| RU (1) | RU94046378A (pt) |
| SI (1) | SI9300350A (pt) |
| SK (1) | SK159994A3 (pt) |
| WO (1) | WO1994000125A1 (pt) |
| ZA (1) | ZA934645B (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5925774A (en) * | 1991-01-07 | 1999-07-20 | Pherin Corporation | Estrenes for inducing hypothalamic effects |
| WO1993023050A1 (en) * | 1992-05-20 | 1993-11-25 | Merck & Co., Inc. | NEW DELTA-17 AND DELTA-20 OLEFINIC AND SATURATED 17β-SUBSTITUTED-4-AZA-5α-ANDROSTAN-3-ONES AS 5α-REDUCTASE INHIBITORS |
| US5543417A (en) * | 1994-10-21 | 1996-08-06 | Merck & Co., Inc. | Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents |
| GB201102913D0 (en) | 2011-02-18 | 2011-04-06 | Univ Birmingham | Novel therapeutic |
| JP2015129095A (ja) | 2013-12-19 | 2015-07-16 | ロレアル | 組成物 |
| BR112020016269A2 (pt) * | 2018-02-11 | 2020-12-15 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Reguladores derivados de esteroides, método para prepará- los e suas utilizações |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4954446A (en) * | 1988-05-25 | 1990-09-04 | Smithkline Beecham Corporation | Aromatic steroid 5-α-reductase inhibitors |
-
1992
- 1992-06-30 GB GB929213835A patent/GB9213835D0/en active Pending
-
1993
- 1993-06-26 ZA ZA934645A patent/ZA934645B/xx unknown
- 1993-06-28 IL IL106158A patent/IL106158A0/xx unknown
- 1993-06-28 MA MA23217A patent/MA22927A1/fr unknown
- 1993-06-30 SI SI9300350A patent/SI9300350A/sl unknown
- 1993-06-30 CZ CZ943346A patent/CZ334694A3/cs unknown
- 1993-06-30 HU HU9403833A patent/HUT69409A/hu unknown
- 1993-06-30 BR BR9306748A patent/BR9306748A/pt not_active Application Discontinuation
- 1993-06-30 AU AU45459/93A patent/AU4545993A/en not_active Abandoned
- 1993-06-30 AP APAP/P/1993/000542A patent/AP412A/en active
- 1993-06-30 MX MX9303970A patent/MX9303970A/es unknown
- 1993-06-30 WO PCT/US1993/006238 patent/WO1994000125A1/en not_active Application Discontinuation
- 1993-06-30 SK SK1599-94A patent/SK159994A3/sk unknown
- 1993-06-30 CA CA002138956A patent/CA2138956A1/en not_active Abandoned
- 1993-06-30 CN CN93109540A patent/CN1095382A/zh active Pending
- 1993-06-30 EP EP93915499A patent/EP0651643A4/en not_active Withdrawn
- 1993-06-30 JP JP6502660A patent/JPH08500821A/ja active Pending
- 1993-06-30 RU RU94046378/04A patent/RU94046378A/ru unknown
-
1994
- 1994-12-29 BG BG99313A patent/BG99313A/xx unknown
- 1994-12-29 KR KR1019940704802A patent/KR950702118A/ko not_active Application Discontinuation
- 1994-12-29 OA OA60599A patent/OA10122A/en unknown
- 1994-12-29 NO NO945074A patent/NO945074L/no unknown
- 1994-12-30 FI FI946189A patent/FI946189A/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2138956A1 (en) | 1994-01-06 |
| BR9306748A (pt) | 1998-12-08 |
| AP412A (en) | 1995-09-29 |
| JPH08500821A (ja) | 1996-01-30 |
| GB9213835D0 (en) | 1992-08-12 |
| AU4545993A (en) | 1994-01-24 |
| FI946189A0 (fi) | 1994-12-30 |
| NO945074L (no) | 1995-02-16 |
| SI9300350A (sl) | 1993-12-31 |
| MA22927A1 (fr) | 1994-04-01 |
| WO1994000125A1 (en) | 1994-01-06 |
| IL106158A0 (en) | 1993-10-20 |
| AP9300542A0 (en) | 1993-07-31 |
| HUT69409A (en) | 1995-09-28 |
| NO945074D0 (no) | 1994-12-29 |
| RU94046378A (ru) | 1996-10-10 |
| BG99313A (en) | 1995-09-29 |
| SK159994A3 (en) | 1996-01-10 |
| OA10122A (en) | 1996-12-18 |
| KR950702118A (ko) | 1995-06-19 |
| EP0651643A4 (en) | 1995-10-04 |
| FI946189A (fi) | 1994-12-30 |
| EP0651643A1 (en) | 1995-05-10 |
| CZ334694A3 (en) | 1995-10-18 |
| CN1095382A (zh) | 1994-11-23 |
| MX9303970A (es) | 1994-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS6456694A (en) | Steroid 5-alpha-reductase inhibitor | |
| AU4251993A (en) | Substituted 4-aza-5A-androstan-ones as 5A-reductase inhibitors | |
| PH30247A (en) | Inhibitor of testosterone 5-alpha-reductase activity | |
| ZA883034B (en) | Steroid 5-alpha-reductase inhibitors | |
| EP0555845A3 (en) | Steroid derivatives | |
| IL105050A0 (en) | Steroid derivatives | |
| AU5323694A (en) | 17beta -carboxanilides of 4-aza-5alpha-androstan-3-ones as 5alpha-reductase inhibitors | |
| ZA934645B (en) | 17-Alkylketone steroids useful as 5-alpha-reductase inhibitors | |
| ZA939338B (en) | New steroids | |
| AU5957794A (en) | Compositions and method for the inhibition of phagocytes | |
| ZA948909B (en) | 7beta-substitute -4-AZA-5alpha-cholestan-ones as selective 5alpha-reductase 1 inhibitors | |
| GB9301969D0 (en) | Push-in nut | |
| IL105527A0 (en) | 17-beta-acyl-aromatic steroid 5-alpha-reductase inhibitors | |
| AU5118493A (en) | Aromatase inhibitor | |
| EP0650358A4 (en) | 17-acyl-4-aza-steroid-3-one as 5-alpha-reductase inhibitors. | |
| GB9303051D0 (en) | 17b-nmonosubstituted carbamoyl-11-oxo-4-aza-5-a-androst-en-3-one testosterone-5-alpha reductase inhibitors | |
| GB9118480D0 (en) | Steroid suphatase inhibitors | |
| IL129131A0 (en) | Inhibitors of testosterone 5- alpha-reductase activity | |
| SI0724592T1 (en) | 16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors | |
| SG177994G (en) | Steroid 5-alpha-reductase inhibitors | |
| AU662224C (en) | New 7beta-substituted-4-aza-5alpha-androstan-3-ones as 5alpha-reductase inhibitors | |
| ZA932980B (en) | 17-substituted-estra-1,3,5(10)-triene-3-carboxylic acids as 5-alpha-reductase inhibitors | |
| EP0707011A4 (en) | STEROLIC COMPOUND | |
| ZA932178B (en) | Steroid derivatives | |
| EP0755378A4 (en) | DIAZOPHENANTHRENONE COMPOUNDS USEFUL FOR INHIBITING 5-ALPHA REDUCTASE |